|
|
||||||||




* The Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom;
Avidex Ltd., Abingdon, United Kingdom; and
Department of Medicine, Imperial College, St. Marys Hospital, London, United Kingdom
HLA class I tetramers have revolutionized the study of Ag-specific CD8+ T cell responses. Technical problems and the rarity of Ag-specific CD4+ Th cells have not allowed the potential of HLA class II tetramers to be fully realized. Here, we optimize HLA class II tetramer staining methods through the use of a comprehensive panel of HIV-, influenza-, CMV-, and tetanus toxoid-specific tetramers. We find rapid and efficient staining of DR1- and DR4-restricted CD4+ cell lines and clones and show that TCR internalization is not a requirement for immunological staining. We combine tetramer staining with magnetic bead enrichment to detect rare Ag-specific CD4+ T cells with frequencies as low as 1 in 250,000 (0.0004% of CD4+ cells) in human PBLs analyzed directly ex vivo. This ultrasensitive detection allowed phenotypic analysis of rare CD4+ T lymphocytes that had experienced diverse exposure to Ag during the course of viral infections. These cells would not be detectable with normal flow-cytometric techniques.
This article has been cited by other articles:
![]() |
K. A. Richards, F. A. Chaves, and A. J. Sant Infection of HLA-DR1 Transgenic Mice with a Human Isolate of Influenza A Virus (H1N1) Primes a Diverse CD4 T-Cell Repertoire That Includes CD4 T Cells with Heterosubtypic Cross-Reactivity to Avian (H5N1) Influenza Virus J. Virol., July 1, 2009; 83(13): 6566 - 6577. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, J. Norimine, G. H. Palmer, W. Mwangi, K. K. Lahmers, and W. C. Brown Rapid Deletion of Antigen-Specific CD4+ T Cells following Infection Represents a Strategy of Immune Evasion and Persistence for Anaplasma marginale J. Immunol., December 1, 2008; 181(11): 7759 - 7769. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Van Overtvelt, E. Wambre, B. Maillere, E. von Hofe, A. Louise, A. M. Balazuc, B. Bohle, D. Ebo, C. Leboulaire, G. Garcia, et al. Assessment of Bet v 1-Specific CD4+ T Cell Responses in Allergic and Nonallergic Individuals Using MHC Class II Peptide Tetramers J. Immunol., April 1, 2008; 180(7): 4514 - 4522. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Crompton, N. Khan, R. Khanna, L. Nayak, and P. A. H. Moss CD4+ T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals Blood, February 15, 2008; 111(4): 2053 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roti, J. Yang, D. Berger, L. Huston, E. A. James, and W. W. Kwok Healthy Human Subjects Have CD4+ T Cells Directed against H5N1 Influenza Virus J. Immunol., February 1, 2008; 180(3): 1758 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Massey, T. J. Scriba, E. L. Brown, R. E. Phillips, and A. K. Sewell Use of Peptide-Major Histocompatibility Complex Tetramer Technology To Study Interactions between Staphylococcus aureus Proteins and Human Cells Infect. Immun., December 1, 2007; 75(12): 5711 - 5715. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Onion, L. J. Crompton, D. W. Milligan, P. A. H. Moss, S. P. Lee, and V. Mautner The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein J. Gen. Virol., September 1, 2007; 88(9): 2417 - 2425. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kasprowicz, A. Isa, T. Tolfvenstam, K. Jeffery, P. Bowness, and P. Klenerman Tracking of Peptide-Specific CD4+ T-Cell Responses after an Acute Resolving Viral Infection: a Study of Parvovirus B19 J. Virol., November 15, 2006; 80(22): 11209 - 11217. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Quiroga, S. Llorente, I. Castillo, E. Rodriguez-Inigo, M. Pardo, and V. Carreno Cellular immune responses associated with occult hepatitis C virus infection of the liver. J. Virol., November 1, 2006; 80(22): 10972 - 10979. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |